慢性自发性荨麻疹的自身免疫发病机制研究进展

doi:10.35541/cjd.20220918

中华皮肤科杂志 ›› 2023, Vol. 56 ›› Issue (6): 567-570.doi: 10.35541/cjd.20220918

• 综述 • 上一篇

慢性自发性荨麻疹的自身免疫发病机制研究进展

张立明肖汀

中国医科大学附属第一医院皮肤科卫健委免疫皮肤病学重点实验室教育部免疫皮肤病学重点实验室免疫性皮肤病诊治技术国家地方联合工程研究中心，沈阳 110001

收稿日期:2022-12-27 修回日期:2023-03-23 发布日期:2023-06-05
通讯作者: 肖汀 E-mail:cmuxt@126.com
基金资助:
国家临床重点专科建设项目重点实验室项目《荨麻疹诊治技术的研发与推广》（［2012］649）

Update of the autoimmune pathogenesis of chronic spontaneous urticaria

Zhang Liming, Xiao Ting

Department of Dermatology, The First Hospital of China Medical University, NHC Key Laboratory of Immunodermatology, Key Laboratory of Immunodermatology of Ministry of Education, National Joint Engineering Research Center for Theranostics of Immunological Skin Diseases, Shenyang 110001, China

Received:2022-12-27 Revised:2023-03-23 Published:2023-06-05
Contact: Xiao Ting E-mail:cmuxt@126.com
Supported by:
National Key Clinical Specialist Subject Construction Project on Urticaria from National Health Commission, China（［2012］649）

摘要/Abstract

摘要： 慢性自发性荨麻疹的自身免疫发病机制在2013年由Konstantinou等提出。近年来，遗传学、表观遗传学、免疫学等方面的研究进展为慢性自发性荨麻疹的自身免疫发病机制提供了支持性证据。

关键词: 慢性自发性荨麻疹, 自身免疫, 遗传学, 进展

Abstract: In 2013, Konstantinou et al have proposed the autoimmune pathogenesis of chronic spontaneous urticaria. In recent years, progresses on genetics, epigenetics and immunology have provided supporting evidences for the autoimmune pathogenesis of chronic spontaneous urticaria.

Key words: Chronic spontaneous urticaria, Autoimmune, Genetics, Update

张立明肖汀. 慢性自发性荨麻疹的自身免疫发病机制研究进展[J]. 中华皮肤科杂志, 2023,56(6):567-570. doi:10.35541/cjd.20220918

Zhang Liming, Xiao Ting. Update of the autoimmune pathogenesis of chronic spontaneous urticaria[J]. Chinese Journal of Dermatology, 2023, 56(6): 567-570.doi:10.35541/cjd.20220918

参考文献 43

［1］	Zuberbier T, Abdul Latiff AH, Abuzakouk M, et al. The international EAACI/GA2LEN/EuroGuiDerm/APAAACI guideline for the definition, classification, diagnosis, and management of urticaria［J］. Allergy, 2022,77（3）:734⁃766. doi: 10.1111/all. 15090.
［2］	Leznoff A, Josse RG, Denburg J, et al. Association of chronic urticaria and angioedema with thyroid autoimmunity［J］. Arch Dermatol, 1983,119（8）:636⁃640. doi: 10.1001/archderm.119. 8.636.
［3］	Grattan CE, Francis DM, Hide M, et al. Detection of circulating histamine releasing autoantibodies with functional properties of anti⁃IgE in chronic urticaria［J］. Clin Exp Allergy, 1991,21（6）:695⁃704. doi: 10.1111/j.1365⁃2222.1991.tb03198.x.
［4］	Hide M, Francis DM, Grattan CE, et al. Autoantibodies against the high⁃affinity IgE receptor as a cause of histamine release in chronic urticaria［J］. N Engl J Med, 1993,328（22）:1599⁃1604. doi: 10.1056/NEJM199306033282204.
［5］	Bar⁃Sela S, Reshef T, Mekori YA. IgE antithyroid microsomal antibodies in a patient with chronic urticaria［J］. J Allergy Clin Immunol, 1999,103（6）:1216⁃1217. doi: 10.1016/s0091⁃6749（99）70204⁃6.
［6］	Konstantinou GN, Asero R, Ferrer M, et al. EAACI taskforce position paper: evidence for autoimmune urticaria and proposal for defining diagnostic criteria［J］. Allergy, 2013,68（1）:27⁃36. doi: 10.1111/all.12056.
［7］	Schoepke N, Asero R, Ellrich A, et al. Biomarkers and clinical characteristics of autoimmune chronic spontaneous urticaria: Results of the PURIST Study［J］. Allergy, 2019,74（12）:2427⁃2436. doi: 10.1111/all.13949.
［8］	Kolkhir P, Altrichter S, Asero R, et al. Autoimmune diseases are linked to type IIb autoimmune chronic spontaneous urticaria［J］. Allergy Asthma Immunol Res, 2021,13（4）:545⁃559. doi: 10. 4168/aair.2021.13.4.545.
［9］	Maronese CA, Ferrucci SM, Moltrasio C, et al. IgG and IgE autoantibodies to IgE receptors in chronic spontaneous urticaria and their role in the response to mmalizumab［J］. J Clin Med, 2023,12（1）:378. doi: 10.3390/jcm12010378.
［10］	Panaszek B, Pawłowicz R, Grzegrzółka J, et al. Autoreactive IgE in chronic spontaneous/idiopathic urticaria and basophil/mastocyte priming phenomenon, as a feature of autoimmune nature of the syndrome［J］. Arch Immunol Ther Exp （Warsz）, 2017,65（2）:137⁃143. doi: 10.1007/s00005⁃016⁃0417⁃7.
［11］	de Montjoye L, Darrigade AS, Giménez⁃Arnau A, et al. Correlations between disease activity, autoimmunity and biological parameters in patients with chronic spontaneous urticaria［J］. Eur Ann Allergy Clin Immunol, 2021,53（2）:55⁃66. doi: 10.23822/EurAnnACI.1764⁃1489.132.
［12］	Oda Y, Fukunaga A, Washio K, et al. Improved FcεRI⁃mediated CD203c basophil responsiveness reflects rapid responses to omalizumab in chronic spontaneous urticaria［J］. J Allergy Clin Immunol Pract, 2021,9（3）:1166⁃1176.e8. doi: 10.1016/j.jaip. 2020.08.048.
［13］	Huang AH, Chichester KL, Saini SS. Association of basophil parameters with disease severity and duration in chronic spontaneous urticaria （CSU）［J］. J Allergy Clin Immunol Pract, 2020,8（2）:793⁃795.e6. doi: 10.1016/j.jaip.2019.08.004.
［14］	Oda Y, Fukunaga A, Washio K, et al. Low responsiveness of basophils via FcεRI reflects disease activity in chronic spontaneous urticaria［J］. J Allergy Clin Immunol Pract, 2019,7（8）:2835⁃2844.e7. doi: 10.1016/j.jaip.2019.05.020.
［15］	Hashimoto T, Yokozeki H, Karasuyama H, et al. IL⁃31⁃generating network in atopic dermatitis comprising macrophages, basophils, thymic stromal lymphopoietin, and periostin［J］. J Allergy Clin Immunol, 2023,151（3）:737⁃746.e6. doi: 10.1016/j.jaci.2022.11.009.
［16］	Kaplan AP, Giménez⁃Arnau AM, Saini SS. Mechanisms of action that contribute to efficacy of omalizumab in chronic spontaneous urticaria［J］. Allergy, 2017,72（4）:519⁃533. doi: 10.1111/all. 13083.
［17］	Kay AB, Ying S, Ardelean E, et al. Calcitonin gene⁃related peptide and vascular endothelial growth factor are expressed in lesional but not uninvolved skin in chronic spontaneous urticaria［J］. Clin Exp Allergy, 2014,44（8）:1053⁃1060. doi: 10.1111/cea. 12348.
［18］	Yanase Y, Takahagi S, Hide M. Chronic spontaneous urticaria and the extrinsic coagulation system［J］. Allergol Int, 2018,67（2）:191⁃194. doi: 10.1016/j.alit.2017.09.003.
［19］	Rauber MM, Pickert J, Holiangu L, et al. Omalizumab response correlates with reduced IFN⁃γ⁃, IL⁃10⁃ and IL⁃31⁃secreting cells in chronic spontaneous urticaria［J］. J Eur Acad Dermatol Venereol, 2020,34（9）:2078⁃2085. doi: 10.1111/jdv.16216.
［20］	Grieco T, Porzia A, Paolino G, et al. IFN⁃γ/IL⁃6 and related cytokines in chronic spontaneous urticaria: evaluation of their pathogenetic role and changes during omalizumab therapy［J］. Int J Dermatol, 2020,59（5）:590⁃594. doi: 10.1111/ijd.14812.
［21］	de Montjoye L, Choteau M, Herman A, et al. IL⁃6 and IL⁃1β expression is increased in autologous serum skin test of patients with chronic spontaneous urticaria［J］. Allergy, 2019,74（12）:2522⁃2524. doi: 10.1111/all.13928.
［22］	Toubi E, Vadasz Z. The emerging role of IL⁃17 in the immune⁃pathogenesis of chronic spontaneous urticaria［J］. Immunotargets Ther, 2020,9:217⁃223. doi: 10.2147/ITT.S266410.
［23］	Sabag DA, Matanes L, Bejar J, et al. Interleukin⁃17 is a potential player and treatment target in severe chronic spontaneous urticaria［J］. Clin Exp Allergy, 2020,50（7）:799⁃804. doi: 10. 1111/cea.13616.
［24］	Auyeung P, Mittag D, Hodgkin PD, et al. Autoreactive T cells in chronic spontaneous urticaria target the IgE Fc receptor Iα subunit［J］. J Allergy Clin Immunol, 2016,138（3）:761⁃768.e4. doi: 10.1016/j.jaci.2016.04.036.
［25］	Bracken SJ, Abraham S, MacLeod AS. Autoimmune theories of chronic spontaneous urticaria［J］. Front Immunol, 2019,10:627. doi: 10.3389/fimmu.2019.00627.
［26］	Kolkhir P, Church MK, Weller K, et al. Autoimmune chronic spontaneous urticaria: what we know and what we do not know［J］. J Allergy Clin Immunol, 2017,139（6）:1772⁃1781.e1. doi: 10.1016/j.jaci.2016.08.050.
［27］	Altrichter S, Peter HJ, Pisarevskaja D, et al. IgE mediated autoallergy against thyroid peroxidase⁃a novel pathomechanism of chronic spontaneous urticaria?［J/OL］. PLoS One, 2011,6（4）:e14794. doi: 10.1371/journal.pone.0014794.
［28］	Atta AM, Rodrigues MZ, Sousa CP, et al. Autoantibody production in chronic idiopathic urticaria is not associated with helicobacter pylori infection［J］. Braz J Med Biol Res, 2004,37（1）:13⁃17. doi: 10.1590/s0100⁃879x2004000100002.
［29］	Concha LB, Chang CC, Szema AM, et al. IgE antithyroid antibodies in patients with Hashimoto′s disease and chronic urticaria［J］. Allergy Asthma Proc, 2004,25（5）:293⁃296.
［30］	Zhang L, Qiu L, Wu J, et al. IgE and IgG anti⁃thyroid autoantibodies in Chinese patients with chronic spontaneous urticaria and a literature review［J］. Allergy Asthma Immunol Res, 2022,14（1）:131⁃142. doi: 10.4168/aair.2022.14.1.131.
［31］	Sánchez J, Sánchez A, Cardona R. Causal relationship between anti⁃TPO IgE and chronic urticaria by in vitro and in vivo tests［J］. Allergy Asthma Immunol Res, 2019,11（1）:29⁃42. doi: 10. 4168/aair.2019.11.1.29.
［32］	Sánchez J, Sánchez A, Cardona R. Clinical characterization of patients with chronic spontaneous urticaria according to anti⁃TPO IgE levels［J］. J Immunol Res, 2019,2019:4202145. doi: 10.1155/2019/4202145.
［33］	Schmetzer O, Lakin E, Topal FA, et al. IL⁃24 is a common and specific autoantigen of IgE in patients with chronic spontaneous urticaria［J］. J Allergy Clin Immunol, 2018,142（3）:876⁃882. doi: 10.1016/j.jaci.2017.10.035.
［34］	Altrichter S, Zampeli V, Ellrich A, et al. IgM and IgA in addition to IgG autoantibodies against FcɛRIα are frequent and associated with disease markers of chronic spontaneous urticaria［J］. Allergy, 2020,75（12）:3208⁃3215. doi: 10.1111/all.14412.
［35］	Kolkhir P, Kovalkova E, Chernov A, et al. Autoimmune chronic spontaneous urticaria detection with IgG anti⁃TPO and total IgE［J］. J Allergy Clin Immunol Pract, 2021,9（11）:4138⁃4146.e8. doi: 10.1016/j.jaip.2021.07.043.
［36］	Johal KJ, Chichester KL, Oliver ET, et al. The efficacy of omalizumab treatment in chronic spontaneous urticaria is associated with basophil phenotypes［J］. J Allergy Clin Immunol, 2021,147（6）:2271⁃2280.e8. doi: 10.1016/j.jaci.2021.02.038.
［37］	O′Donnell BF, O′Neill CM, Francis DM, et al. Human leucocyte antigen classⅡ associations in chronic idiopathic urticaria［J］. Br J Dermatol, 1999,140（5）:853⁃858. doi: 10.1046/j.1365⁃2133.1999.02815.x.
［38］	Brzoza Z, Grzeszczak W, Rogala B, et al. PTPN22 polymorphism presumably plays a role in the genetic background of chronic spontaneous autoreactive urticaria［J］. Dermatology, 2012,224（4）:340⁃345. doi: 10.1159/000339332.
［39］	Sadr M, Khalili N, Mohebbi B, et al. Association of PTPN22 single nucleotide polymorphisms with chronic spontaneous urticaria［J］. Allergol Immunopathol （Madr）, 2021,49（2）:40⁃45. doi: 10.15586/aei.v49i2.53.
［40］	Zhang L, Qiu L, Wu J, et al. GWAS of Chronic spontaneous urticaria reveals genetic overlap with autoimmune diseases, not atopic diseases［J］. J Invest Dermatol, 2023,143（1）:67⁃77.e15. doi: 10.1016/j.jid.2022.07.012.
［41］	Qu S, Yang L, Liu Z. MicroRNA⁃194 reduces inflammatory response and human dermal microvascular endothelial cells permeability through suppression of TGF⁃β/SMAD pathway by inhibiting THBS1 in chronic idiopathic urticaria［J］. J Cell Biochem, 2020,121（1）:111⁃124. doi: 10.1002/jcb.28941.
［42］	Zhang L, Qi R, Yang Y, et al. Serum miR⁃125a⁃5p and CCL17 upregulated in chronic spontaneous urticaria and correlated with treatment response［J］. Acta Derm Venereol, 2019,99（6）:571⁃578. doi: 10.2340/00015555⁃3149.
［43］	Qi Y, Zhang L, Yang X, et al. Genome⁃wide DNA methylation profile in whole blood of patients with chronic spontaneous urticaria［J］. Front Immunol, 2021,12:681714. doi: 10.3389/fimmu.2021.681714.

[1]	焦晴晴张晓艳季江. 慢性自发性荨麻疹活动度相关生物学指标的研究进展[J]. 中华皮肤科杂志, 2023, 56(6): 559-562.
[2]	梁云生黎展宏伍奕蓓. [开放获取] 从发病机制认知变化看慢性自发性荨麻疹治疗进展[J]. 中华皮肤科杂志, 2023, 56(6): 552-558.
[3]	苏畅隋秀丽刘瑞玲曹毅群姜虹严彩蓉王惠平亓玉青. [开放获取] 奥马珠单抗治疗慢性自发性荨麻疹伴有其他过敏性疾病患者74例临床分析[J]. 中华皮肤科杂志, 2023, 56(6): 512-517.
[4]	王鑫刘丽娟李邻峰. [开放获取] 我国慢性自发性荨麻疹临床特征：基于多家医院问卷调查的流行病学研究[J]. 中华皮肤科杂志, 2023, 56(6): 525-530.
[5]	李丽俏彭聪陈翔李捷. [开放获取] 奥马珠单抗治疗对抗组胺药反应不佳的慢性荨麻疹患者单中心回顾性研究[J]. 中华皮肤科杂志, 2023, 56(6): 504-511.
[6]	中华医学会皮肤性病学分会中国医师协会皮肤科医师分会. [开放获取] 慢性自发性荨麻疹达标治疗专家共识（2023）[J]. 中华皮肤科杂志, 2023, 56(6): 489-495.
[7]	于淼宋晓婷刘擘廖双璐栾婷婷赵作涛. 慢性自发性荨麻疹患者自体血清皮肤试验的免疫学机制及与临床特征和预后的关系[J]. 中华皮肤科杂志, 2023, 56(2): 184-187.
[8]	佟馨吴剑张立明高兴华连石张海萍朱威郭在培黎静宜李萌萌何黎农祥普雄明于世荣陈洪铎肖汀. 食物特异性IgG抗体与慢性自发性荨麻疹表型的相关性研究[J]. 中华皮肤科杂志, 2023, 56(2): 130-135.
[9]	赵莹张晓艳陈璐苏玉华丁瑜洁冷红季江. 奥马珠单抗治疗难治性慢性自发性荨麻疹患者的疗效预测因子探索[J]. 中华皮肤科杂志, 2023, 56(1): 22-28.
[10]	刘晋沈征宇. 银屑病表观遗传调控的研究进展[J]. 中华皮肤科杂志, 2022, 55(9): 825-829.
[11]	中国医师协会皮肤科医师分会自身免疫病专业委员会 . 【开放获取】环孢素治疗免疫相关性皮肤病专家建议[J]. 中华皮肤科杂志, 2022, 55(6): 471-479.
[12]	闪莹左亚刚. 自身免疫性疱病与银屑病的相关性[J]. 中华皮肤科杂志, 2022, 55(5): 452-455.
[13]	赵文玲, 杨语嫣, 李丽, 晋红中. 大疱性类天疱疮合并其他免疫性疾病研究进展[J]. 中华皮肤科杂志, 2022, 55(2): 177-181.
[14]	中华医学会皮肤性病学分会中国医师协会皮肤科医师分会. 自身免疫性表皮下大疱病诊疗共识（2022）[J]. 中华皮肤科杂志, 2022, 55(1): 1-11.
[15]	中国医师协会皮肤科医师分会自身免疫性疾病学组. 环磷酰胺治疗自身免疫性皮肤病中国专家共识[J]. 中华皮肤科杂志, 2021, 54(9): 765-770.

慢性自发性荨麻疹的自身免疫发病机制研究进展

Update of the autoimmune pathogenesis of chronic spontaneous urticaria

PDF

可视化

摘要/Abstract

引用本文

使用本文

参考文献 43

相关文章 15

Metrics

本文评价

推荐阅读 10